- Regeneron CEO calls decision ‘setting a new paradigm’
Political pressure is rising in U.S. over cost of medicine
Two of the biggest pharmaceutical companies in the world did something unusual this week when they announced the introduction of breakthrough drugs: they charged less.
If that sounds odd, it is. Drugmakers typically engage in an upwards race to price new medications above older competitors, arguing that the new treatments are worth more because of better effectiveness or fewer side effects. The result has been upward-spiraling list prices in the U.S.
Read Full Story Here >>